Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Infections Post Transplant

Incidence and clinical complications of vancomycin-resistant enterococcus in pediatric stem cell transplant patients

Summary:

Vancomycin-resistant enterococcus (VRE) are increasingly important pathogens in stem cell transplant (SCT). In all, 61 pediatric SCT patients had surveillance stool cultures for VRE between July 1999 and November 2002. When VRE was identified, the patients were placed on strict contact isolation. VRE was detected in 15 patients (24.6%). The median age was 3.6 years (range 0.6–18.5 years). Of the 15, 13 (87%) received an allogeneic transplant (six unrelated and seven related). Five of the 15 (33%) colonized patients developed VRE bacteremia. The bacteremia resolved in all five patients after therapy with quinupristin/dalfopristin; three patients required central line removal. Four patients died (38–153 days) post-SCT due to relapse or transplant complication not related to VRE. Of the 11 surviving patients, seven cleared the colonization at a median of 144 days (range 61–198 days) postcolonization. Four patients remain colonized at 68–702 days after the first positive culture. Intestinal colonization with VRE occurred commonly in pediatric SCT patients. Although the morbidity from VRE was not substantial, transplant patients were colonized for prolonged periods. Our results indicate that surveillance for VRE is an effective way to identify colonized patients and may lead to a decrease in transmission to other patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. LeClercq R, Derlot E, Duval J et al. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988; 319: 157–161.

    Article  CAS  Google Scholar 

  2. Uttley AH, Collins CH, Naidoo J, George RC . Vancomycin-resistant enterococci. Lancet 1988; 1: 57–58.

    Article  CAS  Google Scholar 

  3. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin – United States, 1989–1993. Morb Mortal Wkly Rep 1993; 42: 597–599.

  4. Bakir M, Bova JL, Newell KA et al. Epidemiology and clinical consequences of vancomycin resistant enterococci in liver transplant patients. Transplantation 2001; 72: 1032–1037.

    Article  CAS  Google Scholar 

  5. Orloff SL, Busch AMH, Olyaei AJ et al. Vancomycin-resistant enterococcus in liver transplant patients. Am J Surg 1999; 177: 418–422.

    Article  CAS  Google Scholar 

  6. Patel R, Allen SL, Manahan JM et al. Natural history of vancomycin-resistant enterococcal colonization in liver and kidney transplant recipients. Liver Transplant 2001; 7: 27–31.

    Article  CAS  Google Scholar 

  7. Newell KA, Millis JM, Arnow PM et al. Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation. Transplantation 1998; 65: 439–442.

    Article  CAS  Google Scholar 

  8. Pfundstein J, Roghmann MC, Schwalbe RS et al. A randomized trial of surgical antimicrobial prophylaxis with and without vancomycin in organ transplant patients. Clin Transplant 1999; 13: 245–252.

    Article  CAS  Google Scholar 

  9. Peetermans WE, Sebens FW, Guiot FL . Vancomycin-resistant Enterococcus faecalis in a bone-marrow transplant recipient. Scand J Infect Dis 1991; 23: 105–109.

    Article  CAS  Google Scholar 

  10. Kapur D, Dorsky D, Feingold JM et al. Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2000; 25: 147–152.

    Article  CAS  Google Scholar 

  11. Koc Y, Snydman DR, Schenkein DS, Miller KB . Case report: vancomycin-resistant enterococcal infections in bone marrow transplant recipients. Bone Marrow Transplant 1998; 22: 207–209.

    Article  CAS  Google Scholar 

  12. Edmond MB, Ober JF, Dawson JD et al. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 1996; 23: 1234–1239.

    Article  CAS  Google Scholar 

  13. Shay KD, Maloney SA, Montecalvo MJ . Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis 1995; 172: 993–1000.

    Article  CAS  Google Scholar 

  14. Noskin GA, Cooper I, Peterson LR . Vancomycin-resistant Enterococcus faecium sepsis following persistent colonization. Arch Intern Med 1995; 155: 1445–1447.

    Article  CAS  Google Scholar 

  15. Carretto E, Barbarini D, Locatelli F et al. Vancomycin-resistant Enterococcus faecium infection in three children given allogeneic hematopoietic stem cell transplantation: clinical and microbiological features. Haematologica 2000; 85: 1158–1164.

    CAS  PubMed  Google Scholar 

  16. Gregory JJ, Small TN, Papadopoulos E et al. Influence of vancomycin-resistant enterococcus on the outcome of recipients of bone marrow transplants. Proc Am Soc Clin Oncol 1999; 18: 51a (abstract).

    Google Scholar 

  17. Schuster F, Graubner UB, Schmid I et al. Vancomycin-resistant enterococci – colonization of 24 patients on a pediatric oncology unit. Klin Pediatr 1998; 210: 261–263.

    Article  CAS  Google Scholar 

  18. Singh-Naz N, Sleemi A, Pikis A et al. Vancomycin-resistant Enterococcus faecium colonization in children. J Clin Microbiol 1999; 37: 413–416.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Nourse C, Murphy H, Byrne C et al. Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: risk factors for colonisation. Eur J Pediatr 1998; 157: 20–27.

    Article  CAS  Google Scholar 

  20. Kirkpatrick BD, Harrington SM, Smith D et al. An outbreak of vancomycin-dependent Enterococcus faecium in a bone marrow transplant unit. Clin Infect Dis 1999; 29: 1268–1273.

    Article  CAS  Google Scholar 

  21. Weinstein MR, Dedier H, Brunton J et al. Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium. Clin Infect Dis 1999; 29: 361–363.

    Article  CAS  Google Scholar 

  22. Wong MT, Kauffman CA, Ramoplanin VRE2 Clinical Study Group et al. Effective suppression of vancomycin-resistant Enterococcus species in asymptomatic gastrointestinal carriers by a novel glycolipodepsipeptide, ramoplanin. Clin Infect Dis 2001; 33: 1476–1482.

    Article  CAS  Google Scholar 

  23. Hierholzer WJ, Garner JS, Adam AB . Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Am J Infect Control 1995; 23: 87–94.

    Article  Google Scholar 

Download references

Acknowledgements

We gratefully acknowledge the excellent care provided by the nursing and support staff.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H Frangoul.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tsiatis, A., Manes, B., Calder, C. et al. Incidence and clinical complications of vancomycin-resistant enterococcus in pediatric stem cell transplant patients. Bone Marrow Transplant 33, 937–941 (2004). https://doi.org/10.1038/sj.bmt.1704462

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704462

Keywords

This article is cited by

Search

Quick links